InspireMD (NSPR) Tops Q2 EPS by 19c

InspireMD (NASDAQ: NSPR) reported Q2 EPS of ($0.24), $0.19 better than the analyst estimate of ($0.43). Revenue for the quarter came in at $1.6 million versus the consensus estimate of $1.8 million.

For earnings history and earnings-related data on InspireMD (NSPR) click here.

You May Also Be Interested In

• Worthington Steel, Inc. (WS) Misses Q4 EPS by 3c
• Qualcomm expects $40bn in non-handset revenue by fiscal 2029
• H.B. Fuller (FUL) Tops Q2 EPS by 3c; Offers Outlook